StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.15−0.14 (-5.90%)

Close on Nov 17, 2026Market cap $9.63MP/E –Yield –

Earnings

Bluejay Diagnostics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 5, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2023
–
EPS, Q3 FY2023
-$2.08
-$0.15 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Bluejay Diagnostics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 5, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 13, 2026after the close–––Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Mar 6, 2026before the open–––Release
Q3 FY2023ended Sep 30, 2023Nov 9, 2023after the close––-$2.08Release
Q2 FY2023ended Jun 30, 2023Aug 16, 2023before the open––-$2.75Release
Q1 FY2023ended Mar 31, 2023May 10, 2023during market hours––-$0.12Release
Q4 FY2022ended Dec 31, 2022Mar 20, 2023after the close–––Release
Q3 FY2022ended Sep 30, 2022Nov 8, 2022after the close––-$0.15Release
Q2 FY2022ended Jun 30, 2022Jul 26, 2022during market hours$249.04K–-$0.10Release
Q1 FY2022ended Mar 31, 2022Apr 20, 2022after the close––-$0.10Release
Q4 FY2021ended Dec 31, 2021Mar 10, 2022before the open––-$0.09Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Bluejay Diagnostics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Bluejay Diagnostics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Bluejay Diagnostics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. Update
  4. Update
  5. Update
  6. Update
  7. Update
  8. News
  9. News
  10. Update
  11. Results
  12. Update
  13. Update
  14. Update
  15. Results

See a number that looks wrong?